Trial Profile

COSMOS - COmedication Study Assessing Mono- and cOmbination Therapy With Levodopa-carbidopa inteStinal Gel

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 20 Dec 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

01 Dec 2022 Results of sub analysis (n=401) published in the Parkinsonism and Related Disorders.
28 Jun 2022 Results of post-hoc analysis identifying predictors of optimal motor response with LCIG in APD patients presented at the 8th Congress of the European Academy of Neurology
22 Sep 2021 Results of post-hoc analysis assessing impact of levodopa-carbidopa intestinal gel (LCIG) treatment on dyskinesia duration and severity in advanced Parkinson's disease (APD) patients, presented at the 25th International Congress of Parkinson's Disease and Movement Disorders.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com